Answers are grounded in this paper and cite their sources.
on mumps vaccine effectiveness are not available from India.It is the need of the hour to imprint the need to introduce mumps vaccination in the NIS. 6 IntroductIonA resurgence in mumps, an acute viral illness caused by a singlestranded RNA paramyxovirus, 1 has been noted in the Saraspur region of Ahmedabad.Though a benign condition, mumps virus targets the salivary glands, central nervous system (CNS), testis, pancreas, and to a lesser extent, ovaries, thyroid, heart, kidneys, liver, and synovia. 2 Hence, complications of mumps can be varied and can include encephalitis, orchitis, pancreatitis, etc. 3 It is a vaccine-preventable disease.Indian Academy of Pediatrics (IAP) web-based system and Integrated Disease Surveillance Program network reported 2,892 mumps cases between September 2009 and May 2015. 4 This review highlights that mumps is a public health problem in India; however, inadequate data from different parts of the country underestimate the true extent of the burden.Mumps vaccine is a live attenuated vaccine, available as measles-mumps-rubella (MMR).It can be given at the age of 9 months, 15 months, and 4-6 years as per the IAP immunization guidelines. 5However, since National Immunization Schedule (NIS) doesn't include the mumps vaccine in its schedule, the data 1,
No takes yet. Share an insight, caveat, or question.
Patel et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: